IL25 and asthma: Thus, given that IL-17A and IL-25, which both use, in part, IL-17RA to exert their biological effects, are significantly greater in sputum of obese as compared to non-obese asthmatics [63], future studies focusing on the effectiveness of brodalumab in obese asthma is warranted.